Company Snapshot: IMNX  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Immunex Schedules Investor Conferences for March

    SEATTLE, March 1 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) has
scheduled presentations at the following investor conferences for March 2001.
The conferences, their respective dates and locations are as follows:

    -- US Bancorp Piper Jaffray Pacific Northwest Investor Conference
          March 9, 2001
          Sheraton Seattle Hotel & Towers - Seattle, WA

    -- Fortis Securities
          March 21, 2001
          Hotel Schlosshotel Kronberg - Kronberg, GERMANY

    -- London Bear Stearns Healthcare Conference
          March 23, 2001
          Four Seasons Hotel London - London, ENGLAND

    -- Banc of America Healthcare Conference
          March 27-29, 2001
          Four Seasons Hotel Las Vegas - Las Vegas, NV

   Links to and information about webcasts and replays are available at the
Immunex website at http://www.immunex.com/investor_fs.html.
   Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.

    NOTE:  This news release contains forward-looking statements that involve
risks and uncertainties, including risks associated with clinical development,
regulatory approvals, our reliance on third-party manufacturers, product
commercialization and other risks described from time to time in the SEC
reports filed by Immunex, including the most recently filed Form 10-Q.  An
electronic version of this news release -- as well as additional information
about Immunex of interest to investors, customers, future employees and
patients -- is available on the Immunex home page at http://www.immunex.com.


SOURCE Immunex Corporation




Back to Topback to top

Related links:
  • http://www.immunex.com
    Company News On-Call:
  • http://www.prnewswire.com/comp/434644.html or fax,
    800-758-5804, ext. 434644
    CONTACT:
    media, Kris Greco, 206-470-4871, or
    investors, Mark Leahy 206-389-4363, both of Immunex Corporation